Patients with DH show reduced levels of anti-inflammatory IL-10 and reduced Treg cell numbers in lesional skin compared to healthy skin (115) which indicates the role of Tregs in modulating local inflammatory responses in DH and represents an attractive therapeutic target. This evidence concerns the gene IL10 and dermatitis herpetiformis, familial.